Use of novel antibiograms to determine the need for earlier susceptibility testing and administration for new -lactam/-lactamase inhibitors in the united states

HIGHLIGHTS

• who: Kenneth P. Klinker and colleagues from the u03b2-Lactam/u03b2-Lactamase Inhibitors in the United States Department of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, South Wood St have published the paper: Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New -Lactam/-Lactamase Inhibitors in the United States, in the Journal: Antibiotics 2022, 11, 660. of 12/05/2022
• what: The aim of this review is to emphasize novel antibiogram approaches that are capable of improving the time to and administration for new u03b2-lactam . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.